Unio Capital’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-1,300
| Closed | -$283K | – | 20 |
|
|
2026
Q1 | $283K | Hold |
1,300
| – | – | 0.06% | 17 |
|
|
2025
Q4 | $297K | Hold |
1,300
| – | – | 0.06% | 20 |
|
|
2025
Q3 | $301K | Hold |
1,300
| – | – | 0.07% | 18 |
|
|
2025
Q2 | $241K | Hold |
1,300
| – | – | 0.07% | 18 |
|
|
2025
Q1 | $272K | Hold |
1,300
| – | – | 0.1% | 20 |
|
|
2024
Q4 | $231K | Hold |
1,300
| – | – | 0.08% | 25 |
|
|
2024
Q3 | $257K | Sell |
1,300
-330
| -20% | -$61.6K | 0.1% | 33 |
|
|
2024
Q2 | $280K | Sell |
1,630
-400
| -20% | -$66.3K | 0.12% | 27 |
|
|
2024
Q1 | $370K | Sell |
2,030
-150
| -7% | -$25.9K | 0.16% | 31 |
|
|
2023
Q4 | $338K | Buy |
2,180
+15
| +0.7% | +$2.19K | 0.17% | 35 |
|
|
2023
Q3 | $323K | Hold |
2,165
| – | – | 0.17% | 33 |
|
|
2023
Q2 | $292K | Sell |
2,165
-300
| -12% | -$44K | 0.15% | 36 |
|
|
2023
Q1 | $393K | Sell |
2,465
-1,250
| -34% | -$191K | 0.21% | 33 |
|
|
2022
Q4 | $600K | Hold |
3,715
| – | – | 0.33% | 27 |
|
|
2022
Q3 | $499K | Hold |
3,715
| – | – | 0.3% | 30 |
|
|
2022
Q2 | $569K | Sell |
3,715
-285
| -7% | -$43.5K | 0.33% | 30 |
|
|
2022
Q1 | $648K | Hold |
4,000
| – | – | 0.28% | 36 |
|
|
2021
Q4 | $542 | Hold |
4,000
| – | – | ﹤0.01% | 43 |
|
|
2021
Q3 | $431K | Sell |
4,000
-1
| -0% | -$114 | 0.19% | 37 |
|
|
2021
Q2 | $451K | Sell |
4,001
-2,894
| -42% | -$326K | 0.2% | 36 |
|
|
2021
Q1 | $746K | Hold |
6,895
| – | – | 0.35% | 28 |
|
|
2020
Q4 | $739K | Sell |
6,895
-910
| -12% | -$87.4K | 0.36% | 31 |
|
|
2020
Q3 | $658K | Buy |
7,805
+53
| +0.7% | +$4.99K | 0.36% | 32 |
|
|
2020
Q2 | $761K | Hold |
7,752
| – | – | 0.46% | 28 |
|
|
2020
Q1 | $591K | Buy |
7,752
+3,752
| +94% | +$320K | 0.42% | 29 |
|
|
2019
Q4 | $354K | Sell |
4,000
-200
| -5% | -$16.6K | 0.21% | 49 |
|
|
2019
Q3 | $318K | Sell |
4,200
-250
| -6% | -$17.1K | 0.2% | 52 |
|
|
2019
Q2 | $325K | Sell |
4,450
-4,850
| -52% | -$381K | 0.2% | 48 |
|
|
2019
Q1 | $749K | Hold |
9,300
| – | – | 0.52% | 27 |
|
|
2018
Q4 | $857K | Sell |
9,300
-500
| -5% | -$44K | 0.68% | 25 |
|
|
2018
Q3 | $927K | Sell |
9,800
-1,200
| -11% | -$114K | 0.61% | 26 |
|
|
2018
Q2 | $1.02M | Sell |
11,000
-200
| -2% | -$19.5K | 0.77% | 24 |
|
|
2018
Q1 | $1.06M | Buy |
11,200
+300
| +3% | +$33K | 0.88% | 22 |
|
|
2017
Q4 | $1.05M | Buy |
+10,900
| New | +$1.03M | 0.88% | 23 |
|
Other funds holding ABBV
Unio Capital's ABBV Position: Q2 2026 in Review
Unio Capital sold out of AbbVie (ABBV) in Q2 2026, closing a stake of 1,300 shares — an estimated $283K sold.
Unio Capital first reported a position in ABBV in Q4 2017 and held it in 34 quarters. The position peaked at $1.06M in Q1 2018. 4,187 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Unio Capital reported no remaining AbbVie position as of Q2 2026 after selling out during the quarter.
- Unio Capital sold 1,300 AbbVie shares in Q2 2026, an estimated $283K.
- Unio Capital first reported a position in AbbVie in Q4 2017 and held it in 34 quarters.
- Unio Capital's AbbVie position peaked at $1.06M in Q1 2018.
- 4,187 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Unio Capital's 13F filing for Q2 2026, filed 14 Aug 2026.